Related Experiment Video
Updated: Jun 29, 2026

09:50
Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
9.9K
Computational Insights into Flavonoids for ADAMTS-5 Exosite Inhibition in Knee Osteoarthritis: Docking, MD
Mayurakkhi Bhatia1, Nithyadevi Duraisamy1, Mohammed Cherkaoui1
1Department of Digital Engineering and Artificial Intelligence, College of Science, Long Island University, Brooklyn, NY 11201, USA.
Molecules (Basel, Switzerland)
|March 28, 2026
Summary
Researchers screened flavonoids to find selective inhibitors for ADAMTS-5, a key enzyme in osteoarthritis. Homoeriodictyol showed strong binding to the enzyme
Area of Science:
- Biochemistry
- Computational Chemistry
- Pharmacology
Background:
- Osteoarthritis (OA) pathogenesis involves aggrecan degradation mediated by ADAMTS-5.
- Current ADAMTS-5 inhibitors often lack selectivity, impacting aggrecan integrity.
- Targeting exosites offers a more specific inhibition strategy than catalytic-site inhibition.
Purpose of the Study:
- To identify plant-derived flavonoids that selectively inhibit ADAMTS-5 via exosite interactions.
- To find novel drug-like compounds for treating knee osteoarthritis with improved specificity.
Main Methods:
- In silico screening of 847 flavonoids using high-throughput virtual screening.
- Molecular docking and molecular dynamics simulations targeting ADAMTS-5 exosite domains.
- Drug-likeness, ADME criteria, and structure-activity relationship (SAR) analysis.
Main Results:
- Homoeriodictyol demonstrated the highest binding affinity to the ADAMTS-5 Disintegrin-like domain (-23.1 kcal/mol).
- Molecular dynamics simulations confirmed stable binding of Homoeriodictyol to ADAMTS-5.
- Key residues in the spacer domain involved in ligand binding were identified using a machine-learning model.
Conclusions:
- Homoeriodictyol is a promising candidate for selective ADAMTS-5 exosite inhibition.
- Exosite-targeted inhibition represents a viable strategy for developing novel osteoarthritis therapeutics.
- Computational approaches are effective for discovering targeted enzyme inhibitors.
Related Concept Videos
Predicting Molecular Geometry
VSEPR Theory for Determination of Electron Pair Geometries
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...

